Articolul precedent |
Articolul urmator |
268 1 |
Ultima descărcare din IBN: 2023-12-12 17:17 |
SM ISO690:2012 NEVIN, Varghese. Calitatea vieții la pacienții cu Lupus eritematos sistemic și hipertensiune arterială. In: Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, 21-23 octombrie 2020, Chişinău. Chişinău: USMF, 2020, p. 244. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” 2020 | ||||||
Congresul "Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”" Chişinău, Moldova, 21-23 octombrie 2020 | ||||||
|
||||||
Pag. 244-244 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. Systemic lupus erythematosus (SLE), characterized by multi-system impairment leads to decreased quality of life (QoL). Arterial Hypertension (AHT) is a common commorbidity in these patients, with the potential to affect QoL. Studying the QoL in SLE with associated AHT is a challenge. Objective of the study. To study QoL in patients with SLE and AHT. Material and Methods. Case-control study, in 2 groups of patients: SLE without AHT - group 1, SLE with AHT group 2. QoL was quantified by SF-8 questionnaire, total SF-8 (SF-8t) were calculated, Mental SF-8 (SF-8m) and physical SF-8 (SF-8ph). The results were analyzed in MedcalcStatisticalSoftwear. Results. The study included 23 patients with SLE (SLICC criteria, 2012). The F:M ratio was 14:1, the mean age was 41.2 ± 12.7 years. The duration of the disease was 80.1 ± 42.5 months, SLEDAI activity of 8.0 ± 7.8 points. Group 1 included 11 patients, group 2 included 12. The QoLby SF-8t was 42.9±12.4 p. in group 1 vs 37.7 ± 8.5 p. in group 2 (p> 0.05). The sub-analysis of the QoL (physical and mental) showed that the difference between the groups is based on the physical aspect of the QoL, the mental one being comparable (SF-8ph 41.1±22.8 vs 33.5±7.4 p.) Conclusion. Patients with SLE have decreasedQoL, by physical and mental components. Arterial Hypertension,is a comorbidity frequently associated with SLE,which negatively influences the physical component of QoL, which implies the need for targeted management of BP values in these patients. |
||||||
Cuvinte-cheie SLE, hypertension, quality of life, LES, hipertensiune, Calitatea vieţii |
||||||
|
Dublin Core Export
<?xml version='1.0' encoding='utf-8'?> <oai_dc:dc xmlns:dc='http://purl.org/dc/elements/1.1/' xmlns:oai_dc='http://www.openarchives.org/OAI/2.0/oai_dc/' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd'> <dc:creator>Nevin, V.</dc:creator> <dc:date>2020</dc:date> <dc:description xml:lang='en'><p>Background. Systemic lupus erythematosus (SLE), characterized by multi-system impairment leads to decreased quality of life (QoL). Arterial Hypertension (AHT) is a common commorbidity in these patients, with the potential to affect QoL. Studying the QoL in SLE with associated AHT is a challenge. Objective of the study. To study QoL in patients with SLE and AHT. Material and Methods. Case-control study, in 2 groups of patients: SLE without AHT - group 1, SLE with AHT group 2. QoL was quantified by SF-8 questionnaire, total SF-8 (SF-8t) were calculated, Mental SF-8 (SF-8m) and physical SF-8 (SF-8ph). The results were analyzed in MedcalcStatisticalSoftwear. Results. The study included 23 patients with SLE (SLICC criteria, 2012). The F:M ratio was 14:1, the mean age was 41.2 ± 12.7 years. The duration of the disease was 80.1 ± 42.5 months, SLEDAI activity of 8.0 ± 7.8 points. Group 1 included 11 patients, group 2 included 12. The QoLby SF-8t was 42.9±12.4 p. in group 1 vs 37.7 ± 8.5 p. in group 2 (p> 0.05). The sub-analysis of the QoL (physical and mental) showed that the difference between the groups is based on the physical aspect of the QoL, the mental one being comparable (SF-8ph 41.1±22.8 vs 33.5±7.4 p.) Conclusion. Patients with SLE have decreasedQoL, by physical and mental components. Arterial Hypertension,is a comorbidity frequently associated with SLE,which negatively influences the physical component of QoL, which implies the need for targeted management of BP values in these patients.</p></dc:description> <dc:description xml:lang='ro'><p>Introducere. Lupusul eritematos sistemic (LES) se caracterizează prin afectarea multi-sistemică și duce la diminuarea calității vieții (CV). Hipertensiunea arterială (HTA), comorbiditate frecventă în LES, are potențial de afectare a CV. Studierea CV în cazul asocierii LES cu HTA este o provocare. Scopul lucrării. Studierea CV la pacienții cu LES și HTA. Material și Metode. Studiu caz-control, în 2 grupuri de pacienți: LES fără HTA – grup 1, LES cu HTA – grup 2. CV a fost cuantificată prin chestionarul SF8, au fost calculate SF-8 total (SF-8t), SF-8 mental (SF-8m) și SF-8 fizic (SF-8f). Rezultatele au fost analizate în Medcalc Statistical Softwear. Rezultate. Studiul a inclus 23 de pacienți cu LES (criteriile SLICC,2012). Raportul F:B a fost de 14:1, vârsta medie de 41,2 ±12,7 ani. Durata bolii a fost de 80,1 ± 42,5 luni, activitatea SLEDAI de 8,0 ± 7,8 puncte. În grupul 1 au fost incluși 11 pacienți cu LES fără HTA, grupul 2 a inclus 12 pacienți cu LES și HTA. CV prin SF-8t a constituit 42,9±12.4 p. în grupul 1 versus 37.7±8.5 p. în grupul 2 (p>0.05). Analiza pe compartimente a CV (fizic și mental) a demonstrat că diferența dintre grupuri se bazează pe aspectul fizic al CV, cel mental fiind comparabil pe loturi (SF8f 41.1±22.8 vs 33.5±7.4 p.) Concluzii. Pacienții cu LES au indici ai CV diminuați, prin componentele fizic și mental. Hipertensiunea arterială, comorbiditatea frecvent asociată pacienților cu LES, influențează negativ componentul fizic al CV, ceea ce presupune necesitatea managementului țintit at valorilor TA la acești pacienți.</p></dc:description> <dc:source>Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” () 244-244</dc:source> <dc:subject>SLE</dc:subject> <dc:subject>hypertension</dc:subject> <dc:subject>quality of life</dc:subject> <dc:subject>LES</dc:subject> <dc:subject>hipertensiune</dc:subject> <dc:subject>Calitatea vieţii</dc:subject> <dc:title>Calitatea vieții la pacienții cu Lupus eritematos sistemic și hipertensiune arterială</dc:title> <dc:type>info:eu-repo/semantics/article</dc:type> </oai_dc:dc>